Majid Motovali-Bashi
Overview
Explore the profile of Majid Motovali-Bashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dehbashi M, Hojati Z, Motovali-Bashi M, Ganjalikhani-Hakemi M, Shimosaka A, Cho W
Biol Chem
. 2021 Feb;
402(2):167-178.
PMID: 33544473
Cancer recurrence presents a huge challenge in cancer patient management. Immune escape is a key mechanism of cancer progression and metastatic dissemination. CD25 is expressed in regulatory T (Treg) cells...
12.
Fazeli S, Motovali-Bashi M, Peymani M, Hashemi M, Etemadifar M, Nasr-Esfahani M, et al.
PLoS One
. 2020 Dec;
15(12):e0244776.
PMID: 33378389
[This corrects the article DOI: 10.1371/journal.pone.0240855.].
13.
Norioun H, Motovali-Bashi M, Javadirad S
Int J Reprod Biomed
. 2020 Dec;
18(11):961-968.
PMID: 33349804
Background: The role of and its downstream genes in male fertility has been approved in animal models. Additionally, the expression shrinkage of is significantly correlated with human azoospermia phenotype. Aberrant...
14.
Fazeli S, Motovali-Bashi M, Peymani M, Hashemi M, Etemadifar M, Nasr-Esfahani M, et al.
PLoS One
. 2020 Nov;
15(11):e0240855.
PMID: 33171483
Parkinson's disease (PD) is diagnosed when motor symptoms emerges, which almost 70% of dopamine neurons are lost. Therefore, early diagnosis of PD is crucial to prevent the progress of disease....
15.
Khalilian S, Motovali-Bashi M, Rezaie H
Int J Mol Cell Med
. 2020 Aug;
9(1):33-50.
PMID: 32832483
A major complication in treating hemophilia A is the development of neutralizing antibodies (inhibitors) against therapeutic administered factor VIII (FVIII), which occurs in approximately 20-30% of patients with severe disease....
16.
Sajadpour Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, Khosravi-Farsani N
Hemoglobin
. 2020 Jan;
44(1):27-30.
PMID: 31899996
β-Thalassemia intermedia (β-TI) is a clinical condition characterized by moderate, non transfusional anemia and hepatosplenomegaly. The main objective of this study was to determine the molecular basis of the clinical...
17.
Dehbashi M, Hojati Z, Motovali-Bashi M, Ganjalikhani-Hakemi M, Shimosaka A
Biomol Concepts
. 2019 Sep;
10(1):150-159.
PMID: 31541599
Typically, CD25 is expressed on the cellular surface of regulatory T (Treg) cells. These cells are significant in regulating the self-tolerance and also preventing the immune system from attacking a...
18.
Mehraban M, Motovali-Bashi M, Ghasemi Y
Biochem Biophys Res Commun
. 2019 Sep;
519(1):192-197.
PMID: 31493868
Type II diabetes is a metabolic disease that has affected 460 million people around the globe and become a heavy burden on health care system. Diabetic patients suffer from hyperglycemia...
19.
Sajadpour Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, Yadollahi F
Int J Hematol Oncol Stem Cell Res
. 2019 Aug;
13(2):61-67.
PMID: 31372199
: Beta-thalassemia is one of the most prevalent inherited blood diseases among Iranians. The aim of this study was to elucidate the chromosomal background of beta-thalassemia mutations in Esfahan province,...
20.
Mehraban M, Mansourian M, Ahrari S, HajiEbrahimi A, Odooli S, Motovali-Bashi M, et al.
Comput Biol Chem
. 2019 Jul;
82:25-36.
PMID: 31255972
The prevalence of diabetes mellitus has been incremented in the current century and the need for novel therapeutic compounds to treat this disease has been significantly increased. One of the...